- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Human Papilloma Virus Infection Type 11
Total 8052 results
-
Hospital Clinic of BarcelonaCompletedLiver Transplantation | Hepatitis C Virus InfectionSpain
-
Catholic University of Health and Allied SciencesUniversity of Cambridge; National Institute for Medical Research, TanzaniaUnknownHematologic Diseases | Anemia | Opportunistic Infections | Human Immunodeficiency Virus I Infection | Intestinal Helminthiasis | Intestinal SchistosomiasisTanzania
-
Merck Sharp & Dohme LLCCompletedHepatitis B Virus Infection
-
International Antiviral Therapy Evaluation CenterGilead SciencesCompletedHIV Infections | Hepatitis BNetherlands
-
Georgetown UniversityGlaxoSmithKlineCompletedHuman Immunodeficiency Virus InfectionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHuman Papillomavirus Infection | Human Papillomavirus-Related Malignant NeoplasmCosta Rica
-
Henan Provincial People's HospitalMerck Sharp & Dohme LLCUnknownHIV Infections | Liver Toxicity | Hepatitis Co-infection
-
LumiraDx UK LimitedSuspendedCovid19 | RSV Infection | Influenza Type B | Influenza Type AUnited Kingdom
-
Yangshengtang Co., LtdNot yet recruitingChronic Hepatitis B Virus Infection
-
Universidade Metodista de PiracicabaUniversidade do Estado do ParáRecruitingHuman T-Lymphotropic Virus Type 1 Associated MyelopathyBrazil
-
Centro de Investigación en. Enfermedades Infecciosas...UnknownRecurrent Respiratory PapillomatosisMexico
-
National Institute of Child Health, HungaryMerck Sharp & Dohme LLCUnknownRecurrent Respiratory PapillomatosisHungary
-
Nventa Biopharmaceuticals CorporationCompletedPapilloma | Recurrent Respiratory PapillomatosisUnited States
-
RetroLead (Shanghai) BioPharma Co., Ltd.Not yet recruitingHuman Immunodeficiency Virus-1 (HIV-1) Infection
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusGermany
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxosmithkline/QuintilesCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedInfection, Human Immunodeficiency VirusUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Canada, Portugal, Italy, Belgium
-
ViiV HealthcareGlaxoSmithKlineCompletedEffect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCCompleted
-
Washington University School of MedicineMerck Sharp & Dohme LLCWithdrawnHuman T-cell Leukemia Virus Type 1 Infection